Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The Pros and Cons of Incorporating Transcriptomics in the Age of Precision Oncology

30 May 2019

Abstract excerpt

The treatment of cancer continues to evolve toward personalized therapies based on individual patient and tumor characteristics. Our successes and failures in adopting a precision-oncology approach have demonstrated the utmost importance in identifying the proper predictive biomarkers of response. Until recently, most biomarkers were identified using immunohistochemistry for protein expression or single-gene...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Genomics and Diagnostics
Share to Genetic factors in colorectal cancer
Share to Lung Cancer Treatments and Mutations

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 31165154
DOI: 10.1093/jnci/djz114

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The Pros and Cons of Incorporating Transcriptomics in the Age of Precision OncologyPMID 31165154Read ↗

Precision Oncology: Who, How, What, When, and When Not?Semantic proximity Read ↗

Genomic and transcriptomic profiling expands precision cancer medicine: the WINTHER trialSemantic proximity Read ↗

Molecular profiling for precision cancer therapiesSemantic proximity Read ↗

Precision oncology: current and future platforms for treatment selection.Semantic proximity Read ↗

Precision oncology based on omics data: The NCT Heidelberg experienceSemantic proximity Read ↗

Translating cancer genomes and transcriptomes for precision oncologySemantic proximity Read ↗

Molecular Oncodiagnostics in Precision Oncology: Integrating Tumor Transcriptomics, Patient Pharmacogenetics, and Ex Vivo Chemoresistance Testing to Improve Individual Chemotherapy ResponseSemantic proximity Read ↗

Precision Oncology-Based Targeting of Signaling Pathways toward a Holistic Approach to Cancer TherapeuticsSemantic proximity Read ↗

Omics Profiling in Precision Oncology.Semantic proximity Read ↗

Functional precision oncology: Testing tumors with drugs to identify vulnerabilities and novel combinations.Semantic proximity Read ↗

Whole-genome and transcriptome analysis enhances precision cancer treatment options.Semantic proximity Read ↗

Gene Expression Profiling as a Potential Tool for Precision Oncology in Non-Small Cell Lung CancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.